Ncf1-associated reduced oxidative burst promotes IL-33R+ T cell-mediated adjuvant-free arthritis in mice

Journal of Immunology

Volumn 183, Issue 2, 2009, Pages 874-881

  Hagenow, Kristin ^a,c   Gelderman, Kyra A ^a,d   Hultqvist, Malin ^a,c   Merky, Patrick ^a   Bäcklund, Johan ^a   Frey, Oliver ^b   Kamradt, Thomas ^b   Holmdahl, Rikard ^a  

^a LUND UNIVERSITY   (Sweden)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c Biotech Building   (Sweden)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COLLAGEN TYPE 2; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 33; INTERLEUKIN 33 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN RECEPTOR; NEUTROPHIL CYTOSOLIC FACTOR 1; PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; IL1RL1 PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 33, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ST2L PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DISEASE SEVERITY; EOSINOPHIL; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INJECTION; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DBA MOUSE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; COLLAGEN TYPE II; INTERLEUKIN-5; INTERLEUKINS; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; RESPIRATORY BURST; T-LYMPHOCYTES;

EID: 70249106454     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900966     Document Type: Article

References (49)

1. Segal, B. H., T. L. Leto, J. I. Gallin, H. L. Malech, and S. M. Holland. 2000. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 79: 170-200.
2. Lee, B. W., and H. K. Yap. 1994. Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. Arthritis Rheum. 37: 773-776.
3. Rosenzweig, S. D. 2008. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin. Immunol. 28 (Suppl. 1): S67-S72.
4. Olsson, L. M., A. K. Lindqvist, H. Kallberg, L. Padyukov, H. Burkhardt, L. Alfredsson, L. Klareskog, and R. Holmdahl. 2007. A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res. Ther. 9: R98.
5. Bremell, T., S. Lange, A. Yacoub, C. Ryden, and A. Tarkowski. 1991. Experimental Staphylococcus aureus arthritis in mice. Infect. Immun. 59: 2615-2623.
6. Bremell, T., S. Lange, R. Holmdahl, C. Ryden, G. K. Hansson, and A. Tarkowski. 1994. Immunopathological features of rat Staphylococcus aureus arthritis. Infect. Immun. 62: 2334-2344. (Pubitemid 24157061)
7. Kamradt, T. 2002. Lyme disease and current aspects of immunization. Arthritis Res. 4: 20-29.
8. Quesniaux, V., C. Fremond, M. Jacobs, S. Parida, D. Nicolle, V. Yeremeev, F. Bihl, F. Erard, T. Botha, M. Drennan, et al. 2004. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 6: 946-959.
9. Yip, H. C., A. Y. Karulin, M. Tary-Lehmann, M. D. Hesse, H. Radeke, P. S. Heeger, R. P. Trezza, F. P. Heinzel, T. Forsthuber, and P. V. Lehmann. 1999. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 162: 3942-3949.
10. Chen, Y., J. Inobe, V. K. Kuchroo, J. L. Baron, C. A. Janeway, Jr., and H. L. Weiner. 1996. Oral tolerance in myelin basic protein T cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA 93: 388-391.
11. Bockermann, R., and R. Holmdahl. 2007. Type II collagen without adjuvant induces eosinophilic arthritis. Eur. J. Immunol. 37: 540-548.
12. Olofsson, P., J. Holmberg, J. Tordsson, S. Lu, B. Akerstrom, and R. Holmdahl. 2003. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat. Genet. 33: 25-32. (Pubitemid 36068678)
13. Hultqvist, M., P. Olofsson, J. Holmberg, B. T. Backstrom, J. Tordsson, and R. Holmdahl. 2004. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. USA 101: 12646-12651.
14. Gelderman, K. A., M. Hultqvist, A. Pizzolla, M. Zhao, K. S. Nandakumar, R. Mattsson, and R. Holmdahl. 2007. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J. Clin. Invest. 117: 3020-3028.
15. Hultqvist, M., P. Olofsson, K. A. Gelderman, J. Holmberg, and R. Holmdahl. 2006. A new arthritis therapy with oxidative burst inducers. PLoS Med. 3: e348.
16. Bergsteinsdottir, K., H. T. Yang, U. Pettersson, and R. Holmdahl. 2000. Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J. Immunol. 164: 1564-1568. (Pubitemid 30067274)
17. Becanovic, K., M. Jagodic, J. R. Sheng, I. Dahlman, F. Aboul-Enein, E. Wallstrom, P. Olofsson, R. Holmdahl, H. Lassmann, and T. Olsson. 2006. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J. Immunol. 176: 6055-6064.
18. Huberle, A., A. D. Beyeen, J. Ockinger, M. Ayturan, M. Jagodic, K. L. de Graaf, N. Fissolo, M. Marta, P. Olofsson, M. Hultqvist, et al. 2009. Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of Guillain-Barre Syndrome. J. Immunol. 182: 4432-4438.
19. Wipke, B. T., and P. M. Allen. 2001. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167: 1601-1608.
20. Jackson, S. H., J. I. Gallin, and S. M. Holland. 1995. The p47phox mouse knockout model of chronic granulomatous disease. J. Exp. Med. 182: 751-758.
21. Hultqvist, M., J. Backlund, K. Bauer, K. A. Gelderman, and R. Holmdahl. 2007. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J. Immunol. 179: 1431-1437.
22. Malmstrom, V., E. Michaelsson, H. Burkhardt, R. Mattsson, E. Vuorio, and R. Holmdahl. 1996. Systemic versus cartilage-specific expression of a type II collagen-specific T cell epitope determines the level of tolerance and susceptibility to arthritis. Proc. Natl. Acad. Sci. USA 93: 4480-4485.
23. Mori, L., H. Loetscher, K. Kakimoto, H. Bluethmann, and M. Steinmetz. 1992. Expression of a transgenic T cell receptor β chain enhances collagen-induced arthritis. J. Exp. Med. 176: 381-388.
24. Arai, M., T. Yada, S. Suzuki, and K. Kimata. 1992. Isolation and characterization of type IX collagen-proteoglycan from the Swarm rat chondrosarcoma. Biochim. Biophys. Acta 1117: 60-70.
25. Carlsen, S., S. Lu, and R. Holmdahl. 2007. Arthritis induced with minor cartilage proteins. Methods Mol. Med. 136: 225-242.
26. Smith, B. D., G. R. Martin, E. J. Miller, A. Dorfman, and R. Swarm. 1975. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch. Biochem. Biophys. 166: 181-186.
27. Lohning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935.
28. Vowells, S. J., S. Sekhsaria, H. L. Malech, M. Shalit, and T. A. Fleisher. 1995. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J. Immunol. Methods 178: 89-97.
29. Michaelsson, E., M. Andersson, A. Engstrom, and R. Holmdahl. 1992. Identification of an immunodominant type II collagen peptide recognized by T cells in H-2q mice: self-tolerance at the level of determinant selection. Eur. J. Immunol. 22: 1819-1825.
30. Saxne, T., and D. Heinegard. 1992. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br. J. Rheumatol. 31: 583-591.
31. Arend, W. P., G. Palmer, and C. Gabay. 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223: 20-38.
32. Backlund, J., K. S. Nandakumar, R. Bockermann, L. Mori, and R. Holmdahl. 2003. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model. J. Immunol. 171: 3493-3499.
33. Gelderman, K. A., M. Hultqvist, J. Holmberg, P. Olofsson, and R. Holmdahl. 2006. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc. Natl. Acad. Sci. USA 103: 12831-12836.
34. Lawrence, D. A., R. Song, and P. Weber. 1996. Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation. J. Leukocyte Biol. 60: 611-618.
35. Svendsen, P., C. B. Andersen, N. Willcox, A. J. Coyle, R. Holmdahl, T. Kamradt, and L. Fugger. 2004. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice. J. Immunol. 173: 7037-7045.
36. Svensson, L., K. S. Nandakumar, A. Johansson, L. Jansson, and R. Holmdahl. 2002. IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis. Eur. J. Immunol. 32: 2944-2953.
37. Nandakumar, K. S., and R. Holmdahl. 2006. Arthritis induced with cartilage-specific antibodies is IL-4-dependent. Eur. J. Immunol. 36: 1608-1618.
38. Xu, D., W. L. Chan, B. P. Leung, F. Huang, R. Wheeler, D. Piedrafita, J. H. Robinson, and F. Y. Liew. 1998. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187: 787-794. (Pubitemid 28115194)
39. Coyle, A. J., C. Lloyd, J. Tian, T. Nguyen, C. Erikkson, L. Wang, P. Ottoson, P. Persson, T. Delaney, S. Lehar, et al. 1999. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 190: 895-902.
40. + T cells: induction of type 2 cytokine production by T1/ST2 crosslinking. J. Immunol. 166: 3143-3150.
41. Xu, D., H. R. Jiang, P. Kewin, Y. Li, R. Mu, A. R. Fraser, N. Pitman, M. Kurowska-Stolarska, A. N. McKenzie, I. B. McInnes, and F. Y. Liew. 2008. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 105: 10913-10918.
42. + T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 181: 4780-4790.
43. Schmielau, J., and O. J. Finn. 2001. Activated granulocytes and granulocytederived hydrogen peroxide are the underlying mechanism of suppression of T cell function in advanced cancer patients. Cancer Res. 61: 4756-4760. (Pubitemid 32691887)
44. Peterson, J. D., L. A. Herzenberg, K. Vasquez, and C. Waltenbaugh. 1998. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc. Natl. Acad. Sci. USA 95: 3071-3076.
45. King, M. R., A. S. Ismail, L. S. Davis, and D. R. Karp. 2006. Oxidative stress promotes polarization of human T cell differentiation toward a T helper 2 phenotype. J. Immunol. 176: 2765-2772. (Pubitemid 43306935)
46. Monick, M. M., L. Samavati, N. S. Butler, M. Mohning, L. S. Powers, T. Yarovinsky, D. R. Spitz, and G. W. Hunninghake. 2003. Intracellular thiols contribute to Th2 function via a positive role in IL-4 production. J. Immunol. 171: 5107-5115.
47. phox deficiency induces macrophage dysfunction resulting in progressive crystalline macrophage pneumonia. Am. J. Pathol. 174: 153-163.
48. Raes, G., P. De Baetselier, W. Noel, A. Beschin, F. Brombacher, and G. Hassanzadeh Gh. 2002. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukocyte Biol. 71: 597-602.
49. Webb, D. C., A. N. McKenzie, and P. S. Foster. 2001. Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein. J. Biol. Chem. 276: 41969-41976. (Pubitemid 33690995)